Clinical trials
Terminated Subarachnoid Hemorrhage trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 6 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 44 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor College of Medicine | 2 |
| Edge Therapeutics Inc | 2 |
| Henry Ford Health System | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Aqueduct Critical Care | 1 |
| Brigham and Women's Hospital | 1 |
| C. R. Bard | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Subarachnoid Hemorrhage | 44 |
| Vasospasm, Intracranial | 12 |
| Brain Ischemia | 5 |
| Aneurysm | 4 |
| Intracranial Aneurysm | 4 |
| Brain Injuries | 3 |
| Cerebral Hemorrhage | 3 |
| Stroke | 3 |
| Aneurysm, Ruptured | 2 |
| Brain Injuries, Traumatic | 2 |
Trials
Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.